A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
For those in need, those locations are all in on the fight against drug overdoses. You read that correctly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback